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Alcohol use is an intrinsic part of the pathophysiology 
of alcoholic liver disease (ALD). Understanding the epide-
miology and changing trends in alcohol use in the United 
States and worldwide is important for those who care for 
patients with ALD. ALD is a spectrum of disease, which 
starts with steatosis and progresses to fibrosis and ulti-
mately cirrhosis in approximately 20% to 25% of patients 
who drink heavily over many years.1 Chronic alcohol use of 
approximately 20 to 50 g/day for women or 60 to 80 g/day 
for men increases the risk for alcoholic cirrhosis.2
DeFininG alCOHOl Use
Understanding the epidemiology of alcohol use requires 
understanding definitions of alcohol use and misuse, as well 
as understanding variation in what is considered a stand-
ard drink.3 In the United States, a standard drink contains 
14 g of alcohol and is the equivalent of a 12-ounce can of 
beer, 8 to 9 fluid ounces of malt liquor, a 1/2-ounce shot of 
80 proof spirits, or 5 ounces of wine (Fig. 1). Although the 
definition of a standard drink varies by country, a standard 
drink typically contains approximately 10 to 14 g of alco-
hol.4 Recommendations for safe limits for men and women 
in terms of drinking also vary worldwide; but in general, 
women are advised to drink less than men, typically about 
half as much.
Defining how much alcohol is too much is also criti-
cally important. Moderate alcohol use has been defined 
in the dietary guidelines for the United States as up to 
one drink a day for women or two standard drinks a day 
for men.5 Binge drinking is defined as drinking more than 
four standard drinks for women or more than five stan-
dard drinks for men in a single occasion. Heavy alcohol 
use has been defined as binge drinking 5 or more days in 
the past month.3 Alcohol use disorder (AUD) is defined by 
the use of large and escalating amounts of alcohol over a 
period of time with unsuccessful efforts to cut down; much 
time spent recovering, obtaining, or using alcohol; recurrent 
alcohol use when is physically hazardous; and craving and 
withdrawal.6 The accumulation of more symptoms results 
in a more severe AUD.
GlOBal alCOHOl Use PaTTerns: wHO, 
wHaT, anD HOw MUCH?
Globally, the average per capita alcohol consumption 
per year is approximately 6.4 L, having risen from 5.5 L in 
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2005.7 There is geographic variation in this amount, with 
the lowest amount of per capita alcohol consumption oc-
curring in the Middle East and northern Africa, whereas 
Russia and Europe, particularly Eastern Europe, have some 
of the highest rates of per capita alcohol consumption, al-
though encouragingly, those rates seem to be declining.7,8 
In Europe, the overall per capita consumption of alcohol 
declined from 12.1 to 9.8 L per person from 2000 to 2016, 
and in countries such as Russia, which were among the 
highest consumers of alcohol, per capita consumption de-
clined from 18.7 to 11.7 L over the same time frame.7 By 
contrast, the Western Pacific and Southeast Asia regions 
saw increases in overall per capita alcohol consumption. 
Importantly, however, among drinkers, per capita con-
sumption increased in nearly all regions of the world except 
Europe, indicating that those who do drink at all are drink-
ing more heavily (Fig. 2).7 The types of alcohol consumed 
vary according to geography. Beer consumption made up 
34% of total alcohol consumption and was the most com-
monly consumed alcoholic beverage in North America, 
South America, and Europe. Overall, however, spirits made 
up 45% of global alcohol consumption and were highest 
in the Southeast Asia region (88% of total consumption), 
the Western Pacific (59%), and the Middle East/Eastern 
Mediterranean region (48%).7 Reasons for these global 
variations are complex and include demographic, religious, 
and cultural factors, as well as economic development 
level.
Drinking patterns varied, and binge drinking prevalence 
was reported to be highest in Europe overall with East-
ern European countries, as well as France and England, 
reporting some of the highest rates of binge drinking. 
Encouragingly, however, prevalence of binge drinking 
declined in Europe from 2000 to 2016, decreasing 10% 
to 12% in both the total population and the population 
of active drinkers.7 With respect to gender, unsurprisingly, 
more men than women drink and drink more heavily. 
FIG 1 National Institute on Alcohol Abuse and Alcoholism guidance on US standard drink sizes.
FIG 2 Trends in per capita consumption of alcohol (in liters 
of pure alcohol per year) among active drinkers. Data are from 
the World Health Organization.7 Copyright 2018, World Health 
Organization.
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Worldwide, the proportion of current drinkers was 54% 
of men and 32% of women. The ratio of male to female 
was 3.8. Importantly, these prevalence estimates mask the 
fact that the absolute numbers of drinkers have increased 
given that the population has increased over time as well. 
The absolute numbers of currently drinking women have 
increased worldwide, despite the fact that, compared with 
men, women drink less often and lower amounts of alcohol 
overall.
alCOHOl Use in THe UniTeD sTaTes anD 
elsewHere
National estimates of alcohol use in the United States 
have recently shown alarming figures. Data from the 
National Epidemiologic Survey on Alcohol and Related 
Conditions, a large comprehensive survey conducted in 
the United States since 2001, recently showed that across 
all categories of alcohol use and all demographics, alco-
hol use has risen in the United States from 2001 to 2012.9 
The prevalence of any alcohol use in 12 months rose from 
approximately 65% to just over 72%. This rise was more 
pronounced in women, rural citizens, and those with lower 
socioeconomic status. In addition, minorities showed 
stronger increases across all categories.9 High-risk drinking, 
defined as drinking four to five drinks per day, increased 
by 30%, with more marked increases among women and 
minorities. Among the youngest age group (18-29 years), 
the prevalence rate of high-risk drinking was 19%. The 
most alarming findings, however, show that AUDs, the 
most severe form of alcohol misuse, increased by 50% 
across the 10-year time frame, and this increase was more 
pronounced in women, rising 80% over the time frame.9 In 
addition, AUD rates for the youngest age group, aged 18 
to 29 years, also increased sharply to nearly 25% by 2012. 
Similar trends for alcohol use in other countries have been 
shown. For example, in the United Kingdom, consumption 
of cider, wine, and spirits increased by 150% to 400% over 
a 30-year time frame from 1980 to 2013. Alongside these 
increases was an increase in liver-related mortality in Eng-
land and Wales.10
An important feature of alcohol use epidemiology is the 
comorbid association with both other substance use disor-
ders and other mood disorders. Comorbid alcohol use and 
substance use disorders have been well described, with 
large population-level surveys in the United States showing 
an odds ratio of comorbid substance use disorders ranging 
from 2.2 to 6.4 over a lifetime.11 Tobacco use is an important 
comorbid disorder that commonly occurs alongside alcohol 
use and is known to be a factor in relapse to alcohol use.11,12 
Mood disorders, such as depression and anxiety, are also 
common comorbid mental illnesses in the AUD popula-
tion.11 Maintaining awareness of the common comorbid 
substance use and mental health disorders that may impact 
patients with AUDs is critical for effective long-term man-
agement and mandates a multidisciplinary approach to 
management of patients with ALD.
HealTH COnseQUenCes OF alCOHOl 
Use
Death and disability from alcohol use worldwide are 
high and have increased. In 2016, worldwide alcohol-
attributable mortality was 38.8 per 100,000 people and 
1759 disability-adjusted life-years (DALYs) per 100,000 
people.7 The highest percentage of overall deaths attrib-
utable to alcohol consumption was in Europe at 10.1%. 
Digestive diseases, including liver disease, made up a sub-
stantial portion of these trends, resulting in 8.3 deaths and 
307 DALYs per 100,000 people.7
Importantly, for hepatologists, half of all cirrhosis- 
related deaths worldwide were attributable to alcohol use, 
in whole or in part.7 Alcohol use does have a dose-response 
effect on risk for liver cirrhosis. In a meta-analysis, increas-
ing alcohol consumption, measured in grams per day, was 
associated with an increased relative risk (RR) for cirrho-
sis in both men and women. However, at the same level 
of alcohol, women had an increased risk for cirrhosis. For 
example, at an alcohol consumption level of 48 g/day 
(approximately four standard drinks in the United States), 
the RR for cirrhosis for women was double that for men (RR 
10.1 [95% confidence interval [CI]: 7.5-13.5] for women, 
RR 5.6 [CI: 4.5-7.0]).13 Although it has been suggested that 
low-to-moderate doses of alcohol may be beneficial to 
health, particularly cardiovascular health, these data have 
been called into question recently, with a large-scale study 
showing that current thresholds for “safe” drinking may be 
too high.14 For those with comorbid liver disease, including 
nonalcoholic fatty liver disease or hepatitis C, alcohol use 
appears to accelerate liver damage and hepatic decompen-
sation in those with existing cirrhosis.15,16
Unsurprisingly, given these trends, alcoholic cirrhosis 
prevalence has been shown to be increasing. In a privately 
insured population, the alcoholic cirrhosis prevalence 
rate increased by 43% over the course of a 7-year period, 
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with the prevalence rate in women increasing by 50% 
compared with 30% in men.17 In addition, ALD mortality 
increased in patients aged 25 to 34 years, rising 15% 
over a 10-year period.18 AUDs are common in comor-
bid liver disease, particularly hepatitis C, where the pres-
ence of an AUD increased the risk for decompensation 
by nearly 4-fold.15,19 Furthermore, comorbid AUD with 
hepatitis C results in an earlier age for decompensated 
cirrhosis. In a study comparing the population attribut-
able fraction of decompensation in hepatitis C-related 
cirrhosis, alcohol use was responsible for 13% to 40% 
of decompensating events in geographically diverse 
areas.15 These alarming trends suggest that the rising 
tide of AUDs in the United States may undo the benefits 
of direct-acting antiviral therapy for hepatitis C in many 
patients.
In conclusion, global alcohol trends for some popula-
tions are decreasing, but for others, particularly women, 
they appear to be worsening, especially among active 
drinkers. In the United States, alcohol consumption 
trends are moving in an unfavorable direction, particu-
larly among women, minorities, and those living in rural 
areas. These trends threaten to worsen the burden of 
ALD as well, a burden that is also rising in tandem with 
increases in alcohol use. Efforts to decrease problem 
alcohol use at the policy and patient level are urgently 
needed.
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